CAPITAL INV TRUST CORP NASDAQ BIOTECHNOLOGY ETF TWDCAPITAL INV TRUST CORP NASDAQ BIOTECHNOLOGY ETF TWDCAPITAL INV TRUST CORP NASDAQ BIOTECHNOLOGY ETF TWD

CAPITAL INV TRUST CORP NASDAQ BIOTECHNOLOGY ETF TWD

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪224.78 M‬TWD
Fund flows (1Y)
‪−27.66 M‬TWD
Dividend yield (indicated)
Discount/Premium to NAV

About CAPITAL INV TRUST CORP NASDAQ BIOTECHNOLOGY ETF TWD


Issuer
Qunyi Securities Investment Trust Co. Ltd.
Brand
Capital
Expense ratio
1.01%
Inception date
Jan 9, 2017
Index tracked
NASDAQ Biotechnology Index
Management style
Passive
ISIN
TW0000067800
This fund invests in one basket of United States biotechnology stocks, providing investors with direct participation in the US biotechnology market, which can save investors cost and time. The ETF tracks Nasdaq Biotechnology Index performance as the management target

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of November 6, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks95.52%
Health Technology93.90%
Commercial Services1.33%
Health Services0.29%
Bonds, Cash & Other4.48%
ETF2.27%
Cash2.19%
Miscellaneous0.01%
Stock breakdown by region
98%1%
North America98.04%
Europe1.96%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows